The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis
Clinical trial NCT06393972 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06393972
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-11-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.